News & analysis
Times are shown in BST, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Redx Pharma PLC is a United Kingdom-based biotechnology company focused on the development of novel precision medicines that have the potential to transform treatment in oncology and fibrotic diseases. Its product pipeline under development includes Porcupine Inhibitor, ROCK2 Selective Inhibitor, GI-targeted ROCK inhibitor, Pan-RAF Inhibitor, and others.Redx Pharma PLC is principally engaged in drug discovery, pre-clinical development and licensing. It has an established portfolio of proprietary drug programs that it is developing alone and in partnership with pharmaceutical companies.
Latest REDX News
REDX Regulatory News